Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Protein-protein Interfaces02:04

Protein-protein Interfaces

12.5K
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
12.5K
Protein Networks02:26

Protein Networks

4.0K
An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
4.0K
Ligand Binding Sites02:40

Ligand Binding Sites

12.9K
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
12.9K
Drug Discovery: Overview01:26

Drug Discovery: Overview

7.9K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.9K
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

728
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
728
Protein-Drug Binding: Mechanism and Kinetics01:16

Protein-Drug Binding: Mechanism and Kinetics

520
Protein-drug binding refers to the interaction between drugs and proteins within the body. This binding process can occur intracellularly, involving drug interactions with enzymes or receptors within cells, or extracellularly, involving plasma proteins in the blood.
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...
520

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

On the state of protein function prediction: a report on the fourth CAFA challenge.

bioRxiv : the preprint server for biology·2026
Same author

African digital health strategic plans analysis: key weaknesses in contextualization, intervention focus, and technological foresight.

NPJ digital medicine·2025
Same author

Dataset of Deglet Nour date palm bunches for smart harvesting.

Data in brief·2025
Same author

User journeys in cross-European secondary use of health data: insights ahead of the European Health Data Space.

European journal of public health·2025
Same author

Optimizing Global Network Alignment With a Genetic Algorithm: Leveraging Pre-Trained Embeddings for Protein Sequences and Gene Ontology Terms.

IEEE transactions on computational biology and bioinformatics·2025
Same author

25 Years of Digital Health Toward Universal Health Coverage in Low- and Middle-Income Countries: Rapid Systematic Review.

Journal of medical Internet research·2025

Related Experiment Video

Updated: Jul 8, 2025

A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports
07:35

A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports

Published on: October 13, 2023

1.7K

Advancing drug-target interaction prediction: a comprehensive graph-based approach integrating knowledge graph

Warith Eddine Djeddi1,2, Khalil Hermi3, Sadok Ben Yahia4,5

  • 1LR11ES14, Faculty of Sciences of Tunis, University of Tunis El Manar, Campus Universitaire, 2092, Tunis, Tunisia. waritheddine.jeddi@isikef.u-jendouba.tn.

BMC Bioinformatics
|December 20, 2023
PubMed
Summary

This study introduces DTIOG, a novel computational method for predicting drug-target interactions (DTIs). DTIOG combines knowledge graph embedding with protein sequence context to accurately identify potential DTIs, accelerating drug discovery.

Keywords:
COVID-19Cosine similarityDrug–target interaction predictionKnowledge graph embeddingProtBERT

More Related Videos

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems
05:47

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems

Published on: June 13, 2025

231
Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
08:31

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

5.0K

Related Experiment Videos

Last Updated: Jul 8, 2025

A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports
07:35

A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports

Published on: October 13, 2023

1.7K
Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems
05:47

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems

Published on: June 13, 2025

231
Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
08:31

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

5.0K

Area of Science:

  • Computational biology
  • Pharmacology
  • Bioinformatics

Background:

  • Drug target interaction (DTI) validation is costly and time-consuming, limiting experimental verification.
  • Accurate computational methods are crucial for accelerating drug discovery and predicting potential DTIs.
  • Graph-based machine learning and knowledge graph embedding (KGE) are emerging as powerful tools for DTI prediction.

Purpose of the Study:

  • To develop and evaluate a novel computational approach, DTIOG, for predicting drug-target interactions (DTIs).
  • To leverage knowledge graph embedding and contextual protein sequence information for enhanced DTI prediction accuracy.

Main Methods:

  • DTIOG employs a two-step knowledge graph embedding (KGE) process to compute embedding vectors.
  • Protein Bidirectional Encoder Representations from Transformers (ProtBERT) is utilized to derive contextual information from protein sequences and assess target-target similarity.
  • The approach integrates local representations from drug SMILES strings and protein amino acid sequences.

Main Results:

  • DTIOG demonstrated high efficacy in predicting DTIs across datasets for Enzymes, Ion Channels, and G-protein-coupled Receptors.
  • The method outperformed existing algorithms in DTI prediction accuracy when utilizing various similarity measures and classifiers.
  • The robustness and accuracy of DTIOG were consistently observed across all tested datasets.

Conclusions:

  • DTIOG is a robust and accurate method for predicting drug-target interactions.
  • The proposed approach shows significant potential for accelerating drug discovery by identifying novel DTIs.
  • DTIOG can serve as a valuable tool for researchers in the pharmaceutical field.